carbachol has been researched along with Apolipoprotein B-100, Familial Defective in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Simvastatin did not inhibit development of atheroma." | 1.29 | Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits. Effects of simvastatin treatment. ( Dowell, FJ; Hamilton, CA; Lindop, GB; Reid, JL, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dowell, FJ | 1 |
| Hamilton, CA | 1 |
| Lindop, GB | 1 |
| Reid, JL | 1 |
1 other study available for carbachol and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits. Effects of simvastatin treatment.
Topics: Age Factors; Animals; Aorta; Aorta, Thoracic; Arteriosclerosis; Carbachol; Cholesterol; Endothelium, | 1995 |